Тактика ведення хворих на ревматоїдний артрит лікарем загальної практики–сімейним лікарем
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
«Адаптована клінічна настанова, заснована на доказах. Ревматоїдний артрит», 2014.
Казимирко В.К., Коваленко В.Н. Ревматология: Учебное пособие для врачей в вопросах и ответах. – ИД: Заславский, 2009 – 626 с.
Національний підручник з ревматології. /В.М. Коваленко, Н.М. Шуба, В.К. Казимирко [та ін.]; за ред. В.М. Коваленка, Н.М. Шуби. – К.: МОРІОН, 2013. – 671 с.
Ревматология: национальное руководство / Под ред. Е.Л. Насонова, В.А. Насоновой. – М.: ГЭОТАР Медиа, 2010. – 720 с.
Клинические рекомендации. Ревматология. / Под ред. Е.Л. Насонова. – М.: ГЭОТАР Медиа, 2010.
Наказ Міністерства охорони здоров’я України 11.04.2014 No 263. Уніфікований клінічний протокол первинної, вторинної (спеціалізованої), третинної (високоспеціалізованої) медичної допомоги та медичної реабілітації «Ревматоїдний артрит».
Agarwal S.K. Core Management Principles in Rheumatoid Arthritis to Help Guide Managed Care Professionals // Journal of Managed Care Pharmacy. – 2011. – Vol. 17. – Р. 3–9.
Aletaha D., Neogi T., Silman A.J., et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis., 2010, 69, 1580–8.
Furst D.E., Keystone E.C., Braun J. et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011 // Ann Rheum Dis. – 2012. – Vol. 71, Suppl 2. – Р. 2–45.
Gaujoux Viala C, Nam JL, Ramiro S, et al. Efficacy of conventional synthetic disease modifying antirheumatic drugs, glucocorticoids and tofacitinib a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann. Rheum. Dis. 2013; submitted.
Gorter S., Bijlsma J., Cutolo M. et al. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis // Ann. Rheum. Dis. 2010. – Vol. 69. – Р. 1010–1014.
Knevel R., Schoels M., Huizinga T. et al. Current evidence of a strategic approach to the management of rheumatoid arthritis with the disease modifying anti–rheumatic drugs: a systematic literature review informing the EULAR recommendations for the man agement of rheumatoid arthritis // Ann. Rheum. Dis. – 2010. – Vol. 69. – Р. 987–994.
Lahiri M, Morgan C, Symmons DPM, Bruce IN. Modifiable risk factors for RA: prevention, better than cure. Rheumatology. – 2012; 51: 499–512
Nam J., Winthrop K., Cutolo M. et al. Current evidence for the management of rheumatoid arthritis with biological disease modifying anti–rheumatic drugs: a systematic literature review informing the EULAR recommendations for the man agement of RA // Ann. Rheum. Dis. –2010. – Vol. 69. – Р. 976–986.
Nam J.L., Ramiros S., Gaujoux Viala C., et al. 2013 update of the evidence for the management of rheumatoid arthritis with biological disease modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management RA. Ann. Rheum. Dis. 2013; submitted.
Nikiphorou E., Guh D., Bansback N. et al. Work disability rates in RA. Results from an inception cohort with 24 years follow–up. Rheumatology (Oxford). – 2012. – Vol. 51. – Р. 385–392.
Ramiro S., Gaujoux Viala C., Nam J.L., et al. Safety of synthetic and biological DMARDs a systematic litera ture review informing the 2013 update of the EULAR recommendations for man agement of rheumatoid arthritis. Ann. Rheum. Dis. 2013; submitted.
Smolen J., Aletaha D., Bijlsma J. et al. Treating rheumatoid arthritis to target: recommendations of an international task force // Ann Rheum Dis. – 2010. – Vol. 69. – Р. 631–637.
Smolen J., Landewe R., Breedveld F. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease–modify ing antirheumatic drugs // Ann. Rheum. Dis. – 2010. – Vol. 69. – Р. 964–975.
Smolen JS, van der Heijde D, Machold KP, et al. Proposal for a new nomenclature of disease modifying antirheumatic drugs. Ann. Rheum. Dis. – 2013. – Published Online First: 26 Sep 2013.
Taylor P., Gartemann J., Hsieh J., Greeden J. A systemic review of serum biomarkers anti cyclic citrullinated peptide and r4heumatoid factor as test for rheumatoid arthritis. Autoimmune dis ease 2011; 2011, 18 pages.
Wee M.M., Lems W.F., Usan H. et al. The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review // Ann Rheum Dis. 2012. – Vol. 71. – Р. 161–171.
Whittle S, Colebatch A, Buchbinder R, et al. Multinational evidence based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e initiative. Rheumatology 2012, March 24.
Wollenhaupt J., Albrecht K., Kruger K., et al. The new 2012 German recommendations for treating rheuma toid arthritis : differences compared to the European standpoint. Z. Rheumatol. – 2013;72:6–9.
